Official publication of Rawalpindi Medical University
Red Cell Alloimmunization in Repeatedly Transfused Cancer Patients
PDF

How to Cite

1.
Shahida Mohsin, Sameen Amjad, Huma Amin, Tahir Saeed and ShabbirHussain. Red Cell Alloimmunization in Repeatedly Transfused Cancer Patients. JRMC [Internet]. 2013 Dec. 30 [cited 2024 Mar. 29];17(2). Available from: https://journalrmc.com/index.php/JRMC/article/view/456

Abstract

Background: To determine the frequency and specificities of red blood cells -antibodies in multi-transfused cancer patients. Methods: From total of 150 patients, 24 patients were diagnosed with haematological and 126 with non-haematological malignancies. Their medical records were reviewed and sorted by diagnosis, treatment medications, and past transfusion and/or treatment history. Only those patients were enrolled who had received at least five transfusions during the treatment. Antibody screening was performed by using commercial three-cell panel according to standardized methods. Allo-antibody was identified by using 11 cells panel. Results: Total patients with malignant disorders included 44 males and 106 females. Nine patients (6%) with non haematological malignancies possessed RBC allo-antibodies. The distribution of different allo-antibodies in positive patients was anti-D in 3 patients, anti-E in 2 patients while anti- Fya, anti Fyb, anti-Jka and anti-K were positive for 1 patient in each. The presence of allo-antibodies was statistically significant in patients with higher number of transfusions (p-value 0.001). Conclusion: Allo-antibodies against Rh system were most frequent. Incidence of RBCs allo-immunization increases with the number of transfusion and the number of donor exposures to the recipient.

PDF